QCLS Q/C Technologies, Inc.

0.6367USD+0.74%Mkt Cap: 5.21M $P/E: 0.24

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that r…

Key Statistics

Company
Market Cap5.21M USD
Enterprise Value-1.84M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-11.63M USD
Revenue/Share—
Last Price0.6367 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3
CountryUS
SectorTechnology
IndustryComputer Hardware
ISIN—
Valuation
P/E (Trailing)0.24
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.35
EPS (TTM)2.63
EPS (Forward)—
52W Range
0.44412% of range8.170
52W High8.170 USD
52W Low0.4441 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-53.45%
ROA-28.24%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.07M USD
CapEx (TTM)2.01M USD
FCF Margin—
FCF Yield-114.18%
Net Debt-10.62M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.00
Current Ratio3.29
Quick Ratio3.09
Book Value/Sh1.95 USD
Cash/Share1.34 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateSep 2, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.8.19M
Float7.90M
Insiders7.53%
Institutions9.02%
Short Interest
Short Ratio2.2d
Short % Float106.34%
Short % Out.23.25%
Shares Short1.90M
Short (prev mo.)1.44M
Technical
SMA 501.956 (-67.5%)
SMA 2003.460 (-81.6%)
Beta2.33
S&P 52W Chg16.45%
Avg Vol (30d)9.90M
Avg Vol (10d)4.23M
Technical Indicators
RSI (14)28.0
MACD-0.4067
MACD Signal-0.4463
MACD Hist.+0.0396
BB Upper1.834 USD
BB Middle0.9617 USD
BB Lower0.0890 USD
BB Width181.49%
ATR (14)0.2121 USD
Vol Ratio (20d)0.02x